US0547548588 - Common Stock
Dallas, Texas--(Newsfile Corp. - August 8, 2023) - Stonegate is pleased to announce the...
Aytu BioPharma (AYTU) announced on Friday the pricing of its equity offering of 1.7M shares of its common stock and accompanying Tranche A and Tranche B warrants to purchase 4.3M shares...
AYTU stock earnings show Aytu Biopharma missing earnings per share and revenue estimates for the fiscal third quarter.
We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to know about on Tuesday!
The Nasdaq has granted Aytu BioPharma (AYTU) a 180-day extension to regain compliance with the stock exchange's minimum bid price requirement.AYTU now has until May 22, 2023, to...